Current Issue


Nearly 5% of adults diagnosed with type 2 diabetes in Scotland were in remission in 2019

Compared with people who did not achieve remission, those in remission tended to be older, to have a lower HbA1c level at diagnosis, to have never taken any glucose-lowering medication, to have lost weight since diabetes diagnosis, and to have had bariatric surgery.

No long-term disruption of glycemic control seen after COVID-19, study finds

The authors of a small Italian study of hospitalized COVID-19 patients speculated that reversible transient factors, such as inflammation-induced insulin resistance, may cause the hyperglycemia that occurs in some patients with and without diabetes during infection.

Rates of hypoglycemic, hyperglycemic crises high in patients with diabetes and ESKD

The results of a retrospective study of U.S. data in patients with both diabetes and end-stage kidney disease (ESKD) indicate that current glycemic monitoring and treatment in this population are suboptimal, the authors said.

MKSAP quiz: Draining ulcer on the foot

This month's quiz asks readers to evaluate a 50-year-old with type 2 diabetes and a chronic, nonpainful ulcer on the plantar aspect of his right foot that has recently begun to drain foul-smelling pus.

Spotlight on dementia and glycemic control

Prediabetes and diabetes were associated with development of dementia in a South Korean study, and poorly controlled diabetes was tied to increased risk of incident cognitive impairment or progression to dementia in a Swedish study.

In type 2 diabetes, tirzepatide reduced HbA1c vs. semaglutide

This industry-funded trial of tirzepatide, a unimolecular dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, heralds a new era of “twincretins” in diabetes management, an ACP Journal Club commentary said.